MINNEAPOLIS, May 7, 2020 /PRNewswire/ -- Preventice Solutions announced the publication of real-world data further validating BeatLogic ® deep learning models designed to detect and classify multiple ...

Research identifies guideline-based interpretation gaps and signal-detection issues behind non-actionable alerts and shows how an additional cloud-based AI layer can significantly reduce clinician ...

BOSTON, - Biofourmis announced today that the U.S. Food and Drug Administration (FDA) has granted the company clearance for its RhythmAnalyticsTM platform, a cloud-based software for automated ...

If you are a nurse, doctor or other medical professional that deals with cardiac issues or ECG readings, you owe it to yourself and your patients to take an EKG interpretation course. An EKG ...

In cardiac arrest, the speed and type of treatment can literally mean life or death in the immediate term, but can also affect health outcomes after successful resuscitation. During out-of-hospital ...

GEMS(TM) Rhythm AI Clearance will Address Event, Holter and Long-Term Continuous ECG Monitoring Needs for Remote Patient Monitoring in Canada The GEMS Rhythm arrhythmia and morphology abnormality AI ...

Having an accelerated junctional rhythm occurs when the atrioventricular node in your heart beats too quickly. It happens as a result of damage to your heart’s primary natural pacemaker. There’s no ...

An EKG measures the heart’s electrical activity and can detect various issues, including heart attacks, rhythm abnormalities, and electrolyte imbalances. Seek immediate medical help if you experience ...

Brendan Docherty, MSc, RN, PGCE. Clinical Manager - Cardiology and Critical Care, Queen Elizabeth Hospital NHS Trust, London, and Honorary Fellow, Healthcare Research Unit, City University, London ...

Sudden cardiac death (SCD) is a sudden, unexpected death caused by a change in heart rhythm (sudden cardiac arrest). It is the largest cause of natural death in the U.S., causing between 180,000 to ...

BOSTON, April 30, 2019 /PRNewswire/ -- Biofourmis announced today that the U.S. Food and Drug Administration (FDA) has granted the company clearance for its RhythmAnalytics TM platform, a cloud-based ...